What is MBX Biosciences, Inc.'s earnings yield?

MBX Biosciences, Inc. (MBX) reported earnings yield of -6.1% in Q1 2026.

How has MBX Biosciences, Inc.'s earnings yield changed year-over-year?

MBX Biosciences, Inc.'s earnings yield increased by 79.5% year-over-year, from -29.8% to -6.1%.

What does earnings yield mean?

Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.

MBX Biosciences, Inc. MBX Earnings yield

Earnings yield at other companies

Eli LillyLLY

3.1%+1.6pp

AmgenAMGN

4.1%+0.6pp

Viking TherapeuticsVKTX

-12.6%-31.7pp

Amylyx Pharmaceuticals, Inc.AMLX

-9.8%-4.5pp

BridgeBio PharmaBBIO

-5.1%-1.7pp

Nurix Therapeutics, Inc.NRIX

-18%+0.2pp

Other financials

Income statement

See full

Operating income-$27.3M-2.8%

Net income-$23.5M+1.5%

EPS (diluted)-$0.50+29.6%

Balance sheet

See full

Cash & equivalents$45.2M+51.2%

Total debt$555.0K+327%

Total equity$437.8M+85.9%

Total assets$452.7M+84.1%

Cash flow

See full

Operating cash flow-$20.2M+10.9%

CapEx$437.0K+1,357%

Free cash flow-$20.6M+9.1%

Valuation

See full

Market cap$2.3B+475%

Returns & leverage

See full

Return on equity-25.7%—

Debt / equity0×0.0×

Current ratio30.8×+7.5×

Where this comes from

Calculated from MBX Biosciences, Inc.’s reported figures.

net income/market cap=-6.1%

Based on trailing twelve months.

The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about MBX Biosciences, Inc.'s earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MBX Biosciences, Inc.'s earnings yield?: MBX Biosciences, Inc. (MBX) reported earnings yield of -6.1% in Q1 2026.
How has MBX Biosciences, Inc.'s earnings yield changed year-over-year?: MBX Biosciences, Inc.'s earnings yield increased by 79.5% year-over-year, from -29.8% to -6.1%.
What does earnings yield mean?: Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.